What are the challenges in developing new cancer therapies?
Developing new cancer therapies is a complex and lengthy process. Clinical trials are essential for testing the safety and efficacy of new treatments, but they are time-consuming and expensive. Additionally, the high failure rate of new drug candidates due to lack of efficacy or unacceptable side effects further complicates the development process. Regulatory approvals and market access also pose significant challenges.
